Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiqun Han

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Cancers|July 27, 2022
Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody-Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-AnalysisYan Wang, Hangcheng Xu, Yiqun Han, et al.
Medical Physics|November 29, 2025
Hybrid deep learning reconstruction for fast four-dimensional cone beam computed tomography in small animal imagingYiqun Han, Zengtai Yuan, Yunwen Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform StudyChenyu Sun, Yiqun Han, Abigail Fickel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform StudyChenyu Sun, Yiqun Han, Abigail Fickel, et al.
Frontiers in Oncology|September 12, 2022
CDK4/6 inhibitors versus PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated systematic review and network meta-analysis of 28 randomized controlled trialsHangcheng Xu, Yan Wang, Yiqun Han, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-AnalysisYiqun Han, Jiayu Wang, Yun Wu, et al.
Cancer Medicine|May 22, 2022
Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population-based analysisHangcheng Xu, Yiqun Han, Yun Wu, et al.
International Journal of Nanomedicine|September 5, 2014
Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicinYiqun Han, Ying Zhang, Danni Li, et al.
Pharmaceutical Development and Technology|January 7, 2015
Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapyYiqun Han, Ye Li, Peng Zhang, et al.
Medical Physics|May 29, 2025
A GPU-accelerated Monte Carlo dose engine for external beam radiotherapyZihao Liu, Yuxiang Wang, Yiqun Han, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Cancers|July 27, 2022
Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody-Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-AnalysisYan Wang, Hangcheng Xu, Yiqun Han, et al.
Medical Physics|November 29, 2025
Hybrid deep learning reconstruction for fast four-dimensional cone beam computed tomography in small animal imagingYiqun Han, Zengtai Yuan, Yunwen Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform StudyChenyu Sun, Yiqun Han, Abigail Fickel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform StudyChenyu Sun, Yiqun Han, Abigail Fickel, et al.
Frontiers in Oncology|September 12, 2022
CDK4/6 inhibitors versus PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated systematic review and network meta-analysis of 28 randomized controlled trialsHangcheng Xu, Yan Wang, Yiqun Han, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-AnalysisYiqun Han, Jiayu Wang, Yun Wu, et al.
Cancer Medicine|May 22, 2022
Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population-based analysisHangcheng Xu, Yiqun Han, Yun Wu, et al.
International Journal of Nanomedicine|September 5, 2014
Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicinYiqun Han, Ying Zhang, Danni Li, et al.
Pharmaceutical Development and Technology|January 7, 2015
Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapyYiqun Han, Ye Li, Peng Zhang, et al.
Medical Physics|May 29, 2025
A GPU-accelerated Monte Carlo dose engine for external beam radiotherapyZihao Liu, Yuxiang Wang, Yiqun Han, et al.
Pageof 11